Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF.

Source:http://linkedlifedata.com/resource/pubmed/id/20154271

Proc. Natl. Acad. Sci. U.S.A. 2010 Mar 2 107 9 4299-304

Download in:

View as

Triples

General Info

PMID
20154271